Galaxy Diagnostics
Research Triangle Park, US · North Carolina corporation · 2 known investors
Founders & leadership
AE
Amanda ElamCo-founder
EB
Edward BreitschwerdtCo-founder
BJ
B. Jefferson ClarkExecutive
NB
Nicole BellExecutive
RM
Ricardo MaggiNamed on SEC filing
Board
RW
Richard WestBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$9.7M disclosed across 4 rounds · 2014–2026
▶$3MraisedJun 2026 · 45 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2026 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amanda ElamDirector
- Joel KimbroughDirector
- Nicole BellExecutive Officer, Director
- Edward BreitschwerdtDirector
- B. Jefferson ClarkExecutive Officer, Director
- Richard WestDirector
- Offering amount
- $5.7M
- Amount sold
- $3M
- First sale
- May 2026
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$4.1MraisedApr 2025 · 55 investors · BiotechnologyRule 506(b)
▶$4.1MraisedApr 2025 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward BreitschwerdtDirector
- Amanda ElamExecutive Officer, Director
- Joel KimbroughDirector
- Richard WestDirector
- Nicole BellExecutive Officer, Director
- B. Jefferson ClarkExecutive Officer, Director
- Offering amount
- $11.2M
- Amount sold
- $4.1M
- First sale
- Apr 2025
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$2MraisedJul 2024 · 27 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2024 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amanda ElamExecutive Officer, Director
- B. Jefferson ClarkExecutive Officer, Director
- Nicole BellExecutive Officer, Director
- Edward BreitschwerdtDirector
- Richard WestDirector
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Aug 2023
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$550.8KraisedAug 2014 · 7 investors · BiotechnologyRule 506(b)
▶$550.8KraisedAug 2014 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ricardo MaggiDirector
- Edward BreitschwerdtExecutive Officer, Director, Promoter
- Amanda ElamExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $550.8K
- First sale
- Jul 2014
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapMedscape155 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Labcorp128 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Osmosis101 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Companies competing with Galaxy Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $188.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing - Bay Area Lyme Foundationbayarealyme.org · Jun 2026Frequently asked questions
- Who founded Galaxy Diagnostics?
- Galaxy Diagnostics was founded by Amanda Elam, Edward Breitschwerdt.
- Who are Galaxy Diagnostics's investors?
- Galaxy Diagnostics's investors include Boston Harbor Angels, Wisconsin Investment Partners.
- How much funding has Galaxy Diagnostics raised?
- Galaxy Diagnostics has disclosed $9.7M raised across 4 rounds.
- Where is Galaxy Diagnostics headquartered?
- Galaxy Diagnostics is headquartered in Research Triangle Park, US.
